VSTM
Verastem, Inc.
NASDAQ · USHealthcareBiotechnology
$5.75-4.64%
Price as of Jul 20, 2026
VSTM valuation
Verastem, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 6.67x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.18x
- Price / sales
- 10.19x
- Price / cash flow
- -3.35x
Enterprise value
- Enterprise value
- $409.1M
- EV / sales
- 8.25x
- EV / EBITDA
- -2.13x
- EV / EBIT
- -2.39x
- Market cap
- $505.3M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.